Pediatric inflammatory diseases - Part IV: Miscellaneous, Reye, PRES, sarcoidosis

Neuroradiology Journal

Volumn 25, Issue 6, 2012, Pages 725-738

  Gallucci, Massimo ^a   Smith, J D ^b   Limbucci, N ^c   Rossi, A ^d   Demaerel, P ^e   Krings, T ^f   D'Amico, A ^g   Micheli, C ^h  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b DREXEL UNIVERSITY   (United States)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

^d G GASLINI INSTITUTE   (Italy)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g UNIVERSITY OF TORONTO   (Canada)

^h Rieti Hospital   (Italy)

Author keywords

Neuro Beh et; Neurosarcoidosis; Posterior reversible encephalopathy syndrome; Reye syndrome

Indexed keywords

ACETYLSALICYLIC ACID;

BEHCET DISEASE; BRAIN VASCULITIS; CLINICAL FEATURE; DEMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EMBRYOLOGY; EXTRAPYRAMIDAL SYNDROME; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HYPOTHALAMUS DISEASE; LEPTOMENINX; MENINGOENCEPHALITIS; MOLECULAR BIOLOGY; MULTIPLE SCLEROSIS; NEURORADIOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATHOPHYSIOLOGY; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; REVIEW; REYE SYNDROME; SARCOIDOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VIRUS VIRULENCE; WHITE MATTER LESION;

EID: 84872720268     PISSN: 19714009     EISSN: None     Source Type: Journal    
DOI: 10.1177/197140091202500612     Document Type: Review

References (28)

1. Reye RD, Morgan G, Baral J et al. Encephalopathy and fatty degeneration of the viscera, a disease entity in children. Lancet. 1963; 2: 749-752.
2. Orlowski JP, Hanhan UA, Fiallos MR. Is aspirin a cause of Reye's syndrome? A case against. Drug Saf. 2002; 25: 225-231.
3. Varsik P, Buranová D, Kollár B, et al. Metabolic stroke in three years old boy as the consequence of metabolic derangement. A case report of recidiving Reye's-like syndrome. Neuro Endocrinol Lett. 2006; 27: 13-15.
4. Casteels-Van Daele M, Van Geet C, Wouters C, et al. Reye syndrome revisited: a descriptive term covering a group of heterogeneous disorders. Eur J Pediatr. 2000; 159: 641-648.
5. Thabet F, Durand P, Chevret L, et al. Severe Reye syndrome: report of 14 cases managed in a pediatric intensive care unit over 11 years. Arch Pediatr. 2002; 9: 581-586.
6. Aoki N. Acute toxic encephalopathy with symmetrical low density areas in the thalami and the cerebellum. Child's Nerv Syst. 1985; 1: 62-65.
7. Ozdoba C, Pfenninger J, Schroth G. Initial and followup MRI in a case of early diagnosed Reye's syndrome. Neuroradiology. 1997; 39: 495-498.
8. Kinoshita T, Takahashi S, Ishii K. Reye's syndrome with cortical laminar necrosis: MRI. Neuroradiology. 1996; 38: 269-272.
9. Johnsen SD, Bird CR. The thalamus and midbrain in Reye syndrome. Pediatr Neurol. 2006; 34: 405-407.
10. Milman N, Hoffman AL, Byg K-E. Sarcoidosis in children. Epidemiology in Danes, clinical features, diagnosis, treatment and prognosis. Acta Paediatr. 1998; 87: 871-878.
11. Keesling CA, Frush DP, O'Hara SM, et al. Clinical and imaging manifestations of pediatric sarcoidosis. Acad Radiol. 1998; 5: 122-132.
12. Koné-Paut I, Portas M, Wechsler B, et al. The pitfall of silent neurosarcoidosis. Pediatr Neurol 1999; 20: 215-218.
13. Baumann RJ, Robertson WC. Neurosarcoid presents differently in children than in adults. Pediatrics. 2003; 112: e480-e486.
14. Christofordis GA, Spickler EM, Reccio MV, et al. MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment. Am J Neuroradiol. 1999; 20: 655-669.
15. Miller DH, Kendall BE, Barter S, et al. Magnetic resonance imaging in central nervous system sarcoidosis. Neurology. 1988; 38; 378-383.
16. Sherman JL, Stern BJ. Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images. Am J Neuroradiol. 1990; 11: 915-923.
17. Dumas JL, Valeyre D, Belin C, et al. Central nervous system sarcoidosis: follow-up at MRI during steroid therapy. Radiology. 2000; 214: 411-420.
18. Kari JA, Shah V, Dillon MJ. Behçet's disease in UK children: clinical features and treatment including thalidomide. Rheumatology. 2001; 40: 933-938.
19. Al-Mutawa SA, Hegab SM. Behcet's disease. Clin Exp Med. 2004; 4: 103-131.
20. Saltik S, Saip S, Kocer N, et al. MRI findings in pediatric neuro-Behçet's disease. Neuropediatrics. 2004; 35: 190-193.
21. Tali ET, Atilla S, Keskin T, et al. MRI in neuro-Behçet's disease. Neuroradiology. 1997; 39: 2-6.
22. Lee SH, Yoon PH, Park SJ, et al. MRI Findings in Neuro-Behcet's disease. Clinical Radiology. 2001; 56: 485-494.
23. Koçer N, Islak C, Siva A, et al. CNS involvement in neuro-Behçet syndrome: an MR study. Am J Neuroradiol. 1999; 20: 1015-1024.
24. Vignola S, Nobili F, Picco P, et al. Brain Perfusion SPECT in Juvenile Neuro-Behcet's Disease. J Nucl Med. 2001; 42: 1151-1157.
25. Ozyurek H, Oguz G, Ozen S, et al. Reversible posterior leukoencephalopathy syndrome: report of three cases. J Child Neurol. 2005; 12: 990-993.
26. Pavlakis SG, Frank Y, Chusid R: Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: Three names for an old syndrome. J Child Neurol. 1999; 14: 277-281.
27. Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. Am J Neuroradiol. 2002; 23: 1038-1048.
28. Mukherjee P, McKinstry RC. Reversible posterior leukoencephalopathy syndrome: evaluation with diffusiontensor MR imaging. Radiology. 2001; 219: 756-765.